1. Home
  2. TWO vs DRUG Comparison

TWO vs DRUG Comparison

Compare TWO & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Two Harbors Investment Corp

TWO

Two Harbors Investment Corp

HOLD

Current Price

$13.52

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$80.25

Market Cap

856.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWO
DRUG
Founded
2009
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
856.4M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
TWO
DRUG
Price
$13.52
$80.25
Analyst Decision
Hold
Strong Buy
Analyst Count
6
6
Target Price
$12.31
$106.75
AVG Volume (30 Days)
3.4M
262.0K
Earning Date
02-02-2026
02-13-2026
Dividend Yield
9.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$532,207,999.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
498.21
N/A
52 Week Low
$9.30
$23.18
52 Week High
$14.28
$123.75

Technical Indicators

Market Signals
Indicator
TWO
DRUG
Relative Strength Index (RSI) 69.01 45.56
Support Level $13.12 $81.72
Resistance Level $13.83 $87.58
Average True Range (ATR) 0.59 4.13
MACD 0.04 -1.41
Stochastic Oscillator 77.41 12.38

Price Performance

Historical Comparison
TWO
DRUG

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: